신생아 스크리닝 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Newborn Screening Market size is expected to reach USD 2096.95 Million in 2034 from USD 1034.25 Million (2025) growing at a CAGR of 8.17% during 2026-2034.

The newborn screening market is experiencing significant growth, driven by the increasing awareness of the importance of early detection of congenital disorders and metabolic diseases. As healthcare providers prioritize preventive care and early intervention, the demand for comprehensive newborn screening programs is surging. Advances in technology, such as tandem mass spectrometry and genetic testing, are enhancing the ability to screen for a wide range of conditions, enabling timely diagnosis and treatment. This trend is expected to propel the market forward, as parents and healthcare professionals alike recognize the critical role of newborn screening in improving health outcomes.

Innovations in screening methodologies and technologies are shaping the future of the newborn screening market. The development of non-invasive testing methods and point-of-care testing solutions is improving accessibility and convenience for families, allowing for quicker results and follow-up care. Additionally, advancements in data management and telehealth solutions are streamlining the screening process, facilitating better communication between healthcare providers and families. As research continues to uncover new conditions that can be detected through newborn screening, the market is likely to witness the expansion of screening panels to include additional disorders.

Moreover, the newborn screening market will benefit from increased investment in public health initiatives and regulatory support aimed at enhancing screening programs. Collaborative efforts between healthcare providers, policymakers, and advocacy groups will be essential in promoting awareness and ensuring access to comprehensive newborn screening services. As the landscape evolves, the focus will increasingly shift towards integrating newborn screening into broader maternal and child health strategies, emphasizing the importance of education, follow-up care, and ongoing support in achieving optimal health outcomes for newborns.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Instruments
• Reagents

By Technology

• Tandem Mass Spectrometry
• Pulse Oximetry
• Enzyme Based Assay
• DNA Assay
• Electrophoresis
• Others

By Test Type Outlook

• Dry Blood Spot Test
• CCHD
• Hearing Screen

COMPANIES PROFILED

• BioRad Laboratories, Agilent Technologies, Covidien plc, Masimo, Waters Corporation, Natus Medical, Trivitron Healthcare, GE Lifesciences, PerkinElmer Inc, AB SCIEX

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NEWBORN SCREENING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NEWBORN SCREENING MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Tandem Mass Spectrometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pulse Oximetry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Enzyme Based Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. DNA Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Electrophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NEWBORN SCREENING MARKET: BY TEST TYPE OUTLOOK 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Test Type Outlook
• 6.2. Dry Blood Spot Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. CCHD Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Hearing Screen Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NEWBORN SCREENING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Technology
  • 7.2.3 By Test Type Outlook
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Technology
  • 7.3.3 By Test Type Outlook
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Technology
  • 7.4.3 By Test Type Outlook
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Technology
  • 7.5.3 By Test Type Outlook
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Technology
  • 7.6.3 By Test Type Outlook
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL NEWBORN SCREENING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bio-Rad Laboratories
  • 9.2.2 Agilent Technologies
  • 9.2.3 Covidien Plc
  • 9.2.4 Masimo
  • 9.2.5 Waters Corporation
  • 9.2.6 Natus Medical
  • 9.2.7 Trivitron Healthcare
  • 9.2.8 GE Lifesciences
  • 9.2.9 PerkinElmer Inc
  • 9.2.10 AB SCIEX